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1 The opening of cardiac plasma-membrane ATP-sensitive Kþ channels (pmKATP) can protect the
heart against ischaemia/reperfusion injury. We recently demonstrated that the resting membrane
potential (Em) of ventricular myocytes strongly modulates reoxygenation-induced Ca
2þ overload.
This led to the hypothesis that activation of pmKATP can influence the extent of chemically induced
hypoxia (CIH)/reoxygenation Ca2þ overload via hyperpolarization of the diastolic membrane
potential of ventricular myocytes.
2 The membrane potential (Em) of isolated rat myocytes was determined using the perforated patch-
clamp technique and DiBac4(3) imaging. Intracellular Ca
2þ ([Ca2þ ]i) was monitored using FURA-2
imaging.
3 CIH/reoxygenation caused a significant depolarization of Em and a substantial increase in [Ca
2þ ]i.
The KATP opener pinacidil (100 mM) and the pmKATP opener P-1075 (100mM) hyperpolarized the Em of
normoxic myocytes. Pinacidil (100mM) and P-1075 (10 and 100mM), applied during reoxygenation,
hyperpolarized Em and prevented reoxygenation-induced increases in [Ca
2þ ]i.
4 Myocyte hypercontracture and death increased in parallel with an Em depolarization of 10–15mV
and increases in [Ca2þ ]i. Under these conditions, the selective pmKATP channel inhibitor HMR 1098
further depolarized myocyte membrane potential and increased hypercontracture.
5 In conclusion, activation of pmKATP channels can prevent CIH/reoxygenation-induced Ca
2þ
overload via a mechanism that is dependent on hyperpolarization of diastolic membrane potential.
Hyperpolarization toward normal resting membrane potential favours the Ca2þ extrusion mode of
Naþ /Ca2þ exchange.
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Introduction
In the time period following the discovery of ATP-sensitive
potassium (pmKATP) channels in cardiac tissue (Noma, 1983),
many studies have demonstrated that pharmacological activa-
tion of KATP channels under hypoxic or ischaemic conditions
can result in protection of the myocardium (Cole et al., 1991;
McPherson et al., 1993; Hearse, 1995; Light et al., 2001). In the
mammalian myocardium, two distinct classes of KATP
channels are expressed in (i) the plasma membrane (pm) and
the (ii) mitochondrium (mito). There is an ongoing debate
regarding the mechanism(s) of action of potassium channel
openers that results in cardioprotection. There is also
uncertainty and controversy surrounding the putative roles
of pm and mitoKATP channels in affording this protection (for
recent reviews, see Gross & Fryer, 1999; Gross & Peart, 2003).
Activation of mitoKATP channels is thought to improve
mitochondrial function via regulation of mitochondrial
volume, calcium-handling and/or mitochondrial membrane
potential (see the review by O’Rourke, 2000). However, recent
work by Das et al. (2003) argues against a significant
functional role of a sulphonylurea-inhibitable mitoKATP
channel. Several compelling lines of evidence indicate that
activation of pmKATP channels is also cardioprotective. For
example, pmKATP channel-deficient (KO) mouse hearts failed
to exhibit preconditioning. In wild-type hearts, this ‘compro-
mised’ state could be mimicked by the selective pmKATP
channel inhibitor HMR1098 (Suzuki et al., 2002). Also, a
recent work by Suzuki et al. (2003) suggests that the
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cardioprotective effects of diazoxide, long considered to be a
selective mitoKATP opener, is in fact mediated mainly by the
activation of pmKATP channels. Our recent findings demon-
strate that activation of pmKATP channels can significantly
reduce hypoxia-induced calcium overload in rat ventricular
myocytes (Light et al., 2001). Despite these findings, the
cellular ionic mechanisms by which pharmacological activa-
tion of pmKATP in the heart elicits a cardioprotective effect
remain to be established.
Significant and maintained increases in intracellular calcium
(Ca2þ overload) are generally thought to be a key determinant
of the severity of myocardial damage during ischaemia/
reperfusion (IR) (Marba´n et al., 1989; Park & Lucchesi,
1999; Piper & Garcia-Dorado, 1999). Dysfunctional intracel-
lular Ca2þ homeostasis during reperfusion is thought to
represent a major determinant of the early phase of reperfu-
sion injury, including stunning and cell hypercontracture/
death (Marba´n et al., 1989; Tani, 1990; Bolli & Marba´n, 1999).
However, many of the underlying mechanisms responsible for
the observed calcium overload have not been demonstrated.
Recent findings strongly suggest that alterations in the activity
of the plasma-membrane Naþ /Ca2þ exchanger contributes to
abnormal Ca2þ regulation during ischaemia/reperfusion (Eigel
& Hadley, 2001; Scha¨fer et al., 2001), and it is known that the
severity of myocyte calcium overload is dependent on
transmembrane electrochemical gradients for Naþ and Ca2þ
(Blaustein & Lederer, 1999). Our previous results have shown
that: (i) pmKATP channel activation by protein kinase C
reduces reoxygenation-induced calcium overload (Light et al.,
2001) and (ii) hyperpolarization of the diastolic/resting
membrane potential reduces the magnitude of calcium over-
load mediated by reverse-mode Naþ /Ca2þ exchange (Baczko´
et al., 2003a).
Accordingly, the main goal of the present study was to
determine the relationship between: (i) pharmacological
activation of the repolarizing Kþ current pmKATP, (ii) the
diastolic membrane potential, (iii) calcium overload and
myocyte hypercontracture, in the setting of chemically induced
hypoxia (CIH)/reoxygenation. Our findings confirm that
activation of pmKATP hyperpolarizes the diastolic membrane
potential, and demonstrate that this is essential for reducing
hypoxia/reoxygenation-induced calcium overload and irrever-
sible myocyte injury.
Part of this work has been recently presented in abstract
form (Baczko´ et al., 2003b).
Methods
Resting membrane potential measurements using
perforated patch-clamp and DiBac4(3) fluorescence-
imaging techniques
Adult rats were euthanized with pentobarbital (150mg kg1,
i.p.) according to the University of Alberta Animal Policy and
Welfare Committee and the Canadian Council on Animal
Care (CCAC) Guidelines. The hearts were removed under
complete anaesthesia and right ventricular myocytes were then
obtained by enzymatic dissociation using the standard proto-
cols described previously (Bouchard et al., 1993; Light et al.,
1998). Changes in the resting membrane potential of freshly
isolated myocytes were estimated by monitoring changes in
fluorescence intensity of the potentiometric bisoxonol dye bis-
(1,3-dibutylbarbituric acid)trimethine oxonol (DiBac4(3)), an
anionic probe that, upon changes in membrane potential,
partitions into the myocyte sarcolemma and exhibits enhanced
fluorescence on depolarization (Epps et al., 1994). Conversely,
hyperpolarization leads to efflux of the probe and a decrease in
fluorescence intensity. Right ventricular myocytes were in-
cubated with 2mM DiBac4(3) for 20min to achieve homo-
genous probe distribution in the myocyte sarcolemma. After
incubation, cells were placed on coverslips for observation at
 200 with an inverted microscope (Olympus, CK40) and were
superfused with the control solution containing 2mM Di-
Bac4(3) and (in mM): NaCl 140, KCl 5, HEPES 10, CaCl2 2.0,
MgCl2 1.4, glucose 10. A Photon Technology International
(PTI, Lawrenceville, NJ, U.S.A.) imaging system with PTI
Imagemaster software (version 1.49) was used for data
acquisition and analysis. DiBac4(3) was excited with 470 nm
wavelength light and the emitted light intensity at 525 nm was
digitized and stored. Normalized values were expressed as the
ratio of F(test)/F(control), where F(test)¼ 525 nm wavelength
fluorescence intensity at a given time point in test conditions
and F(control) is the mean 525 nm fluorescence intensity
during the stable 2min control period, before the application
of test solutions. The resting membrane potentials of
DiBac4(3)-loaded right ventricular myocytes were measured
using the perforated-patch technique similar to our previous
study (Baczko´ et al., 2003a). The cardiomyocytes were then
voltage-clamped at selected potentials (–90 to –50mV, every
10mV) and simultaneous DiBac4(3) fluorescence intensity
measurements were carried out on the same cells at 351C.
The DiBac4(3) fluorescence intensity at the resting membrane
potential was defined as 1.0 during normalization (Figure 1a).
To demonstrate that the changes in Em observed using
DiBac4(3) imaging were maintained for the duration of our
experimental protocols, ventricular myocytes were superfused
with 2.5, 10mM [Kþ ]o for 18min and their DiBac4(3)
fluorescence was monitored (Figure 1b). Membrane potential
measurements and DiBac4(3) imaging experiments were
performed at 35711C.
Measurements of intracellular Ca2þ ([Ca2þ]I)
A sustained increase in [Ca2þ ]i has been reported to correlate
closely with cell mortality in the setting of ischaemia/
reperfusion (for a review, see Bolli & Marba´n, 1999).
Accordingly, continuous measurements of [Ca2þ ]i have been
used as an indicator of calcium homeostasis in models of CIH/
reoxygenation (Jovanovic et al., 1998). Right ventricular
myocytes from adult rats were loaded for 15min with the
esterified form of the Ca2þ -sensitive fluorescent probe FURA-
2-AM (2 mM, dissolved in a 50% dimethyl sulphoxide and a
50% vv1 pluronic acid mixture (Molecular Probes, Eugene,
OR, U.S.A.)). After loading, cells were washed and placed on
coverslips for observation at  200 with an inverted micro-
scope (Olympus, CK40), while being superfused with the
control solution containing (in mM): NaCl 140, KCl 5, HEPES
10, CaCl2 2.0, MgCl2 1.4, or with selected test solutions. A
Photon Technology International (PTI, Lawrenceville, NJ,
U.S.A.) imaging system with PTI Imagemaster software
(version 1.49) was used for data acquisition and analysis.
FURA-2 was excited with alternating 340 and 380 nm
wavelengths of light, and the emitted light intensity at
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520 nm was digitized and stored. An estimate of [Ca2þ ]i was
obtained from the calculated 340/380 nm ratio. Normalized
values were expressed as the ratio F(test)/F(control), where
F(test)¼ the image ratio of 340/380 nm at a given time point in
test conditions and F(control) is the mean image ratio of 340/
380 nm measured during the stable 2min normoxic period,
before the application of the solutions which resulted in
hypoxic insult. In each successful protocol, myocytes were
subjected to 8min of CIH (5mM 2-deoxy-glucose and 4mM
NaCN) and then 8min of reoxygenation in the normal
solution. All experimental solutions contained 100 mM probe-
necid, an inhibitor of the uric acid transporter system, to slow
FURA-2-AM leakage from the cells (Di Virgilio et al., 1990).
Results from only those myocytes that did not develop
hypercontracture during CIH/reoxygenation are included in
the figures, which illustrate changes in [Ca2þ ]i during CIH or
reoxygenation. All Ca2þ -imaging experiments were carried out
at 35711C.
Drugs and chemicals
1-[[5-[2-(5-chloro-o-anisamido)ethyl]-2-methoxyphenyl]sulpho-
nyl]-3-methylthiourea, sodium salt (HMR 1098) (Aventis,
Frankfurt, Germany) was dissolved as a 5mM stock solution
in distilled water. Pinacidil (Sigma Chemical Co., St Louis,
MO, U.S.A.), P-1075 (Tocris, Ellisville, MO, U.S.A.) and
Probenecid (Sigma Chemical Co., St Louis, MO, U.S.A.) were
made up as 10, 10 and 100mM stock solutions in dimethyl
sulphoxide, respectively. Pluronic F-127 (Molecular Probes,
Eugene, OR, U.S.A.) was prepared as a 20% wv1 stock
solution in dimethyl sulphoxide. Each stock solution was
diluted to the required concentration immediately before use.
Statistical analysis
Data are presented as means7s.e.m. Statistical significance
was evaluated using Student’s unpaired and paired t-test, as
appropriate, with Origin 6.0 software. Myocyte hypercontrac-
ture data were analysed using the w2 method with Yates’
correction. A level of Po0.05 was considered to be statistically
different.
Results
Effects of Em and selected [K
þ]o on DiBac4(3)
fluorescence
Measurements using the perforated patch-clamp technique
from five adult rat ventricular myocytes loaded with 2mM
DiBac4(3) yielded the following resting membrane potential:
74.2570.86mV. So that changes in DiBac4(3) fluorescence in
our imaging experiments could be correlated with changes in
membrane potential, these myocytes were voltage-clamped
and changes in DiBac4(3) fluorescence were assessed
(Figure 1a).
To show that we were able to qualitatively monitor changes
in resting membrane potential by measuring changes in
DiBac4(3) fluorescence for the duration of our experiments,
myocytes were superfused with Tyrode’s solution containing
10mM [Kþ ]o to elicit depolarization, and 2.5mM [K
þ ]o to
induce hyperpolarization of the resting membrane potential.
Our data demonstrate that the changes in resting membrane
potential of ventricular myocytes caused by the application of
selected [Kþ ]o are well maintained and monitored by
DiBac4(3) imaging (Figure 1b).
Effect of pharmacological activation and inhibition of
IK-ATP on the Em of adult rat ventricular myocytes
Pharmacological activation of plasma-membrane KATP by
100 mM pinacidil and P-1075 significantly hyperpolarized the
resting membrane potential of normoxic rat ventricular
myocytes (Figure 2a). However, 10mM P-1075 induced only
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Figure 1 Effects of diastolic membrane potential (Em) and selected
[Kþ ]o on DiBac4(3) fluorescence in right ventricular myocytes
isolated from adult rat hearts. (a) Cardiomyocytes were voltage-
clamped using the perforated patch-clamp technique. At selected
membrane potentials, changes in DiBac4(3) fluorescence intensity
(DF) were assessed and DF was used as an estimate of relative Em
changes in subsequent imaging experiments. DF was normalized in
each cell to F measured at the resting membrane potential, which
averaged –74.2570.86mV (n¼ 5 cells). The line was fitted by linear
regression. (b) Note that 2.5mM [Kþ ]o hyperpolarized, and 10mM
[Kþ ]o depolarized the Em of quiescent, normoxic myocytes.
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a transient and very limited hyperpolarization in normoxic
myocytes. The time course of reaching the maximal hyperpo-
larization (approximately 1min) was similar in 100mM
pinacidil- and 100mM P-1075-treated groups (Figure 2a). As
expected, HMR 1098 (100mM) did not change the resting
membrane potential of ventricular myocytes in normoxic
conditions (Figure 2a).
In the next set of experiments, myocytes were subjected to
8min of CIH and 8min reoxygenation with test solutions. All
groups of myocytes were superfused with a Tyrode’s solution
with the same composition until the end of the CIH period.
CIH was followed by reoxygenation by one of the test
solutions. Test solutions were control solution containing the
KATP openers pinacidil and P-1075, the pmKATP inhibitor
HMR 1098 or the combination of P-1075 and HMR 1098. The
control group was reoxygenated with control solution only.
Our rationale for administering these compounds only in
reoxygenation was to pharmacologically activate or inhibit
KATP only upon reoxygenation, since our previous work
suggested a distinct protective role for pmKATP during
reoxygenation (Light et al., 2001).
CIH caused a similar, progressive depolarization of
myocytes in each group (Figure 2b)
No significant change in resting membrane potential was
observed in myocytes superfused with the control solution
during reoxygenation; the myocytes remained depolarized
(increase in normalized F was 5.171.28% by the end of
reoxygenation vs the end of CIH, P40.05; Figure 2b).
However, application of the KATP openers pinacidil and the
pmKATP selective P-1075 (10 and 100mM) in the reoxygenation
solution significantly hyperpolarized the Em of myocytes close
to baseline values (normalized DF compared to baseline was
0.9870.02, 1.0770.05 and 0.9670.03 vs 1.2570.07 in
controls at the end of reoxygenation, respectively, Po0.05;
Figure 2b).
Effect of depolarization and hyperpolarization of the
resting membrane potential on Ca2þ loading during CIH
and reoxygenation
CIH induced a progressive increase in [Ca2þ ]i (increase in
Fura-2 ratio was 16.970.36%; Figure 3b, control group). This
was followed by a further rise in [Ca2þ ]i during reoxygenation
(increase in Fura-2 ratio was 9.870.18%; Figure 3b, control
group).
As expected, superfusion of myocytes with Tyrode’s solution
containing 15mM [Kþ ]o caused a depolarization, while
subsequent application of 2.5mM [Kþ ]o caused hyperpolariza-
tion of the resting membrane potential, with respect to the Em
estimated during superfusion with 5mM [Kþ ]o (Baczko´ et al.,
2003a; Figure 1b). In the next set of experiments, the influence
of resting membrane potential on [Ca2þ ]i was evaluated. A
4min exposure to 15mM [Kþ ]o significantly increased [Ca
2þ ]i
(increase in Fura-2 ratio was 7.070.58% vs baseline, Po0.01;
Figure 3a). The CIH-induced Ca2þ loading was significantly
larger in the myocytes depolarized with 15mM [Kþ ]o
(36.170.94% vs 16.970.36% in controls superfused with
5mM [Kþ ]o during CIH, Po0.001; Figure 3a, b). Importantly,
reoxygenation-induced elevation of [Ca2þ ]i was reduced
markedly in cardiac myocytes hyperpolarized with Tyrode’s
solution containing 2.5mM [Kþ ]o (change in Fura-2 ratio was
–13.370.97 vs 13.571.1% in myocytes reoxygenated with
15mM [Kþ ]o, Po0.001; Figure 3a). Note that the Fura-2 ratio
at the end of the reoxygenation period was reduced compared
to that at the end of the CIH period (1.3170.009 vs
1.4470.053, Po0.05; Figure 3a). These results are in
agreement with our recent study showing that the resting
membrane potential of cardiac myocytes is a critical determi-
nant of CIH/reoxygenation-induced Ca2þ overload (Baczko´
et al., 2003a). In the course of the imaging experiments, some
myocytes developed hypercontracture either during CIH or
reoxygenation, which was preceded by a rapid increase in
[Ca2þ ]i. These myocytes were no longer viable; thus, they were
excluded from evaluation of [Ca2þ ]i, but were included in the
evaluation of cell hypercontracture (Table 1).
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Figure 2 Effect of pharmacological activation and inhibition of
pmKATP on resting membrane potential in right ventricular myocytes
isolated from adult rat hearts. (a) Pinacidil (100 mM) and P-1075
hyperpolarized, while 10 mM P-1075 and 100mM HMR 1098 did not
change the Em of normoxic myocytes. (b) Pinacidil and the pmKATP
selective P-1075 hyperpolarized the chemical hypoxia-induced
depolarized Em of myocytes towards EK. Pinacidil, P-1075 and
HMR 1098 were applied during reoxygenation only. *Po0.05 vs
baseline (a) or vs control (b), n¼ 6 experiments, 2–5 cells per
experiment.
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Pinacidil and P-1075 prevent and HMR 1098 increases
reoxygenation-induced Ca2þ loading via a mechanism
involving hyperpolarization of the diastolic resting
membrane potential
In addition to causing resting membrane potential
hyperpolarization upon reoxygenation (Figure 2b), pinacidil
and P-1075 (10 and 100 mM) significantly reduced
reoxygenation-induced increase in [Ca2þ ]i (increases in nor-
malized Fura-2 ratio were 4.970.78, 0.470.26 and 1.470.29
vs 9.870.18% in controls, respectively, Po0.05; Figure 3b
and 4b). HMR 1098 (100 mM) significantly increased
reoxygenation-induced Ca2þ loading (increase in normalized
Fura-2 ratio was 20.570.61 vs 9.870.18% in controls,
Po0.05; Figure 3b).
Both 2.5mM [Kþ ]o and pmKATP activation resulted in
hyperpolarization of the resting membrane potential (Figures
1b and 2b) and consequent protection against increases in
[Ca2þ ]i during reoxygenation. A difference between the
findings shown in Figures 3a and b can be noted, however.
Reoxygenation with 2.5mM [Kþ ]o caused a significant
decrease in [Ca2þ ]i compared to the end of the CIH period
(normalized Fura-2 ratios were 1.3170.01 at the end of
reoxygenation vs 1.4470.05 at the end of CIH, Po0.05;
Figure 3a). Reoxygenation with 100 mM P-1075 prevented
further increase of [Ca2þ ]i during reoxygenation (normalized
Fura-2 ratios were 1.1570.02 at the end of reoxygenation vs
1.1470.02 at the end of CIH, P40.05; Figure 3b).
We calculate that in myocytes superfused with 15mM [Kþ ]o
during CIH and with 2.5mM [Kþ ]o during reoxygenation
(Figure 3a), the change in membrane potential is approxi-
mately 30mV by the end of reoxygenation (EK at 15mM [K
þ ]o
minus EK at 2.5 [K
þ ]o). On the other hand, in myocytes
superfused with 5mM [Kþ ]o both during CIH and reoxygena-
tion (Figure 3b), 100mM P-1075 hyperpolarizes the cell by
approximately 8–10mV (Em during CIH (Figure 2b) minus EK
of –85mV at 5mM [Kþ ]o). These results further suggest and
are in agreement with our previous study (Baczko´ et al., 2003a)
showing that changes in resting membrane potential
are critical in the development of reoxygenation-induced
Ca2þ loading.
HMR 1098 blocks the protective effect of P-1075 during
reoxygenation
The presence of 100mM HMR 1098 in the reoxy-
genation solution prevented the hyperpolarizing effect of
10 mM P-1075 (Figure 4a), and blocked the protective effect
of 10 mM P-1075 on reoxygenation-induced Ca2þ overload
(Figure 4b).
Activation and inhibition of pmKATP and reoxygenation-
induced myocyte hypercontracture
The resting membrane depolarization and increased Ca2þ
overload showed good correlation with the increased number
of hypercontracted cells in DiBac4(3) and Fura 2 imaging
experiments. We use the term hypercontracture to describe
myocytes exhibiting completely irreversible pathophysiological
behaviour; this included dramatic cell shortening (480% of
original cell length), and/or losing their rod-shaped cellular
morphology (rounding up), and blebbing of the sarcolemma.
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Figure 3 Effect of depolarization and hyperpolarization of Em
on CIH/reoxygenation (CIH/Reox) Ca2þ overload. (a) De-
polarization of myocytes (in 15mM [Kþ ]o) caused a progressive
increase in [Ca2þ ]i during CIH/Reox. Hyperpolarization of the
myocyte (following superfusion with 2.5mM [Kþ ]o) prevented the
reoxygenation-induced increase in [Ca2þ ]i. (b) Pharmacological
activation of pmKATP by 100 mM pinacidil and P-1075 reduced,
pmKATP inhibition by 100 mM HMR 1098 enhanced reoxygenation-
induced increase in [Ca2þ ]i. All compounds were applied during
reoxygenation only. *Po0.05 vs control, n¼ 6 experiments, 2–5 cells
per experiment.
Table 1 Percentage of cardiomyocyte hypercontrac-
ture during reoxygenation
Drug in reoxygenation n Hypercontracted
myocytes (%)
Control 23 44
100mM pinacidil 28 11*
10mM P-1075 32 13*
100mM P-1075 27 7*
100mM HMR 1098 24 75*
10mM P-1075+100 mM
HMR 1098
22 47
n is the number of cardiomyocytes subjected to reoxygena-
tion. *Po0.05 vs control group.
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These morphological changes were accompanied by a massive,
irreversible membrane potential depolarization and large
increases in [Ca2þ ]i. Pharmacological activation of pmKATP
channels by 100mM pinacidil, 10 and 100mM P-1075
significantly decreased the number of ventricular myocytes
that hypercontracted during reoxygenation (Table 1).
Conversely, reoxygenation of myocytes with Tyrode’s solution
containing 100 mM of the pmKATP inhibitor HMR 1098
(Go¨gelein et al., 2000) significantly increased cell hyper-
contracture and death (Table 1). The incidence of cell
death in the group of ventricular myocytes reoxygenated
with the combination of 10 mM P-1075 and 100 mM HMR 1098
was not statistically significant from controls (Table 1). This
result was in agreement with those showing that 100 mM HMR
1098 prevented the resting membrane potential hyperpolariz-
ing effect (Figure 4a), and blocked the protective effect of
10 mM P-1075 on reoxygenation-induced Ca2þ overload
(Figure 4b).
Discussion
Summary
Our findings provide important new evidence that activation
of the plasma-membrane KATP current in mammalian ventricle
can reduce reoxygenation-induced increases in [Ca2þ ]i, and
show that this is due to hyperpolarization of the resting
membrane potential. This hyperpolarization of the diastolic
membrane potential by pmKATP activation markedly reduces
the number of myocytes that hypercontract and die. In
contrast, inhibition of pmKATP increases both Ca
2þ loading
and the incidence of myocyte hypercontracture in the setting of
hypoxia/reoxygenation.
Rationale of findings
The potentiometric dye DiBac4(3), which functions as a
qualitative monitor of membrane potential (Em) and provides
reproducible estimates of changes in Em, was employed in this
study. To correlate changes in membrane potential and
DiBac4(3) fluorescence, DiBac4(3)-loaded rat ventricular myo-
cytes were voltage-clamped and the DiBac4(3) fluorescence was
measured (Figure 1a). To test the hypothesis that the
deleterious effects of increases in intracellular calcium con-
centration [Ca2þ ]i resulting from CIH and subsequent
reoxygenation can be reduced by hyperpolarization of the
diastolic membrane potential following pmKATP activation,
changes in the membrane potentials of rat ventricular
myocytes were followed by DiBac4(3) imaging during CIH/
reoxygenation in the presence or absence of pharmacological
pmKATP activation. Our rationale (Pandit et al., 2001) is that
this manoeuvre moves the membrane potential into a range
where the Naþ /Ca2þ exchanger can more effectively extrude
Ca2þ in the presence of a normal electrochemical gradient for
Naþ (Bouchard et al., 1993; Pandit et al., 2001).
Our data confirm that DiBac4(3) can qualitatively monitor
depolarizations and hyperpolarizations from the normal
resting potential in rat ventricular myocytes (Figure 1a, b),
and that these changes in Em are maintained for the duration
of the experimental protocols used in this study (Figure 1b). In
mammalian ventricular myocardium, this finding is important
for two reasons:
(i) A hyperpolarization (approximately 8–10mV) to a stable
membrane potential is essential for this experimental design,
since reductions in [Kþ ]o to 2.5mM may, in isolated myocytes
(e.g. which are compromised as a result of the enzymatic
dispersion procedure), lead to oscillations between two levels
of Em. This is due to the ion–ion interaction in the background
inwardly rectifying Kþ current which controls the resting
membrane potential (Pandit et al., 2001). A significant stable
hyperpolarization is a requirement for the manoeuvres, which
yield data that test our working hypothesis.
(ii) DiBac4(3) reports changes in membrane potential
through time-dependent partitioning into the myocyte sarco-
lemma. For this reason, it may be toxic. Our experimental
design involves subtle, voltage-dependent interactions between
potassium channels (Kir 2.1) and antiporter mechanisms
(Naþ /Ca2þ exchanger). Our findings (Figure 1a, b), however,
provide no evidence for any toxic effects of DiBac4(3) when
used in isolated cardiomyocytes, under the conditions de-
scribed in this paper.
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Figure 4 (a) HMR 1098 (100 mm) prevents the hyperpolarization of
resting membrane potential produced by 10 mM P-1075 during
reoxygenation. (b) HMR 1098 (100 mM) blocks the protective effect
of 10 mM P-1075 on reoxygenation-induced Ca2þ overload. All
compounds were applied during reoxygenation only. *Po0.05 vs
control, n¼ 6 experiments, 2–5 cells per experiment.
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Pharmacological activation and inhibition of plasma-
membrane KATP
The main goal of this study was to determine whether
pharmacological activation of the population of ATP-sensitive
potassium channels which are expressed predominantly in the
sarcolemma can ameliorate myocyte damage due to elevated
[Ca2þ ]i, following CIH/reoxygenation. For this reason, it was
essential to activate sarcolemmal KATP channels as opposed to
those expressed in the mitochondria. The available literature
suggests that P-1075 functions in this capacity (Liu et al.,
2001), and our findings are consistent with this supposition.
Liu et al. have shown that P-1075, even in the highest
concentration used in this study (100mM), does not activate
native mitoKATP channels. We also used pinacidil, a non-
selective KATP channel opener with a chemical structure very
similar to P-1075, for further confirmation of the effect of
KATP channel activation on reoxygenation-induced Ca
2þ
overload.
The time course of the onset of the effects of KATP openers
on resting membrane potential and reoxygenation-induced
Ca2þ overload averaged approximately 1min, which makes it
unlikely that the hyperpolarization observed following P-1075
application, even at this high concentration, was mediated by
mitochondrial KATP channel activation. As shown by Sato et al.
(2000), KATP channel openers elicit their effect on mitochon-
drial function in 5–10min.
ATP-sensitive potassium channels consist of a hetero-
octamer of four inwardly rectifying pore-forming potassium
channel subunits (Kir6.2) together with four regulatory
sulphonylurea receptor subunits (SUR) (Inagaki et al., 1995).
Distinct isoforms of the SUR expressed in different tissues lead
to well-defined pharmacological characteristics of the ex-
pressed KATP channel. In the plasma membrane of cardiac
myocytes and skeletal muscle, SUR2A is the SUR isoform
(Inagaki et al., 1996).
In the present study, HMR 1098, a cardioselective
sulphonylurea, was used for the inhibition of ventricular
myocyte KATP channels (Go¨gelein et al., 2000). The pharma-
cological profile of mitochondrial KATP closely resembles the
Kir6.1/SUR1 (Liu et al., 2001). A recent study from our
laboratory shows that HMR 1098 selectively inhibits the
pmKATP isoform Kir6.2/SUR2A, as opposed to Kir6.1/SUR1
(Manning Fox et al., 2002). This same study also shows that
HMR 1098 (10–1000 mM) did not have an effect on Kir2.1
current (Manning Fox et al., 2002). Also, evidence from recent
work using pinacidil and [3H]P-1075 demonstrates that the
target site for potassium channel opener binding and selectivity
is the C-terminal of the sulphonylurea receptor complex
(Schwanstecher et al., 1998). The results of these studies
suggest that it is very unlikely that the resting membrane
potential changes seen in our experiments were due to the
effects of pinacidil, P-1075 or HMR 1098 on the background
inwardly rectifying Kþ current (IK1).
Activation of plasma-membrane IK-ATP hyperpolarizes the
resting membrane potential and provides cardioprotection
It has been suggested that the activation of mitoKATP as
opposed to pmKATP plays an important role in cardioprotec-
tion (reviewed by Gross & Fryer, 1999). This suggestion is
based on pharmacological studies using diazoxide and
5-hydroxydecanoate (5-HD) as a mitoKATP opener and
blocker, respectively (Garlid et al., 1997; Liu et al., 1998).
However, diazoxide has been shown to cause flavoprotein
oxidation through a mechanism independent of its mitoKATP
activation (Grimmsmann & Rustenbeck, 1998; Hanley et al.,
2002), and can open pmKATP at low concentration in the
presence of ADP (D’Hahan et al., 1999), and to protect
cardiac myocytes during metabolic inhibition without causing
mitochondrial depolarization or flavoprotein oxidation (Law-
rence et al., 2001). Also, 5-HD can be a substrate and/or
inhibitor of fatty acid b-oxidation (Hanley et al., 2003).
Accordingly, these effects of diazoxide and 5-HD could
contribute to their ability to mimic and/or block the effects
of ischaemic preconditioning.
We are aware that a number of papers have been published
recently, suggesting a critical role for pmKATP in cardioprotec-
tion in the setting of ischaemia/hypoxia and reperfusion/
reoxygenation. Cotransfection of COS-7 cells with the Kir6.2/
SUR2A genes encoding the cardiac pmKATP isoform resulted
in decreased hypoxia/reoxygenation-induced Ca2þ loading
(Jovanovic et al., 1998). Also, Suzuki et al. (2002) have shown
that the infarct size-reducing effect of ischaemic precondition-
ing is abolished in Kir6.2-deficient mice. Another recent study
from their laboratory suggests that diazoxide exerts its
cardioprotective effects via the pmKATP channels due to its
ability to significantly improve post-ischaemic functional
recovery only in mice hearts expressing the pmKATP channel
as opposed to Kir6.2 knockout hearts (Suzuki et al., 2003).
Our results confirm that activation of pmKATP plays an
important role in protecting ventricular myocytes against
hypoxia/reoxygenation injury: in the present study, pharma-
cological activation of pmKATP by pinacidil and P-1075, a
pmKATP selective pinacidil analogue, significantly decreased
reoxygenation-induced Ca2þ overload (Figure 3b), an effect
that was blocked by the pmKATP inhibitor HMR 1098
(Figure 4b). We also show that reoxygenation of myocytes in
the presence of Tyrode’s solution containing 2.5mM [Kþ ]o
significantly reduced reoxygenation-induced Ca2þ overload in
cardiac myocytes (Figure 3a). These results confirm our recent
observations, which demonstrate the beneficial effects of
hyperpolarization of the resting membrane potential on
reoxygenation-induced Ca2þ overload by altering Naþ /Ca2þ
exchanger activity (Baczko´ et al., 2003a). In agreement, the
membrane potential hyperpolarizing effect of pmKATP openers
observed in this study in reoxygenation after hypoxia-induced
membrane depolarization (Figure 2b) is accompanied by a
reduction in Ca2þ overload (Figure 3b). Based on our previous
observations and on the present study, we propose that the
modulation of Naþ /Ca2þ exchanger-mediated Ca2þ entry by
hyperpolarization of the resting membrane potential as a
consequence of pmKATP activation is an essential component
of the mechanism responsible for the cardioprotection offered
by ATP-sensitive potassium channel opening in ventricular
myocytes.
Implications for cardioplegia
The heart is subjected to elective global ischaemia during
cardiac surgery or cardiac transplantation. The application of
cardioplegic solutions arrests the heart and preserves its
postoperative function. However, some aspects of the post-
operative cardiac dysfunction observed in the majority of
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patients can, at least in part, be attributed to the use of
hyperkalaemic cardioplegic solutions (Leung, 1993; Cohen
et al., 1995). The results from our previous (Baczko´ et al.,
2003a) and present study (Figure 1b, 3a) show that the
increased [Kþ ]o, used in hyperkalaemic cardioplegic solutions
(induction: 23mM, maintenance: 13mM; Fukuhiro et al.,
2000),depolarizes myocytes. This diastolic depolarization can
lead to increased Ca2þ overload and cell hypercontracture/
death upon reperfusion. A number of strategies have been
utilized to reduce Ca2þ overload during experimental cardi-
oplegia. These include: (i) lowering [Ca2þ ]o in a Mg
2þ -
containing solution (Fukuhiro et al., 2000), (ii) addition of
the sodium channel blocker tetrodotoxin (Snabaitis et al.,
1997), (iii) application of the Naþ /Hþ exchanger inhibitor
HOE-642 (Fukuhiro et al., 2000) and (iv) addition of KATP
openers. It is known that the KATP opener pinacidil can
enhance cardioprotection compared to cardioplegic solution
alone (Hosoda et al., 1994). The observation that another
KATP opener, lemakalim, protected rat hearts undergoing
hypothermic cardioplegia when given alone, but failed to
improve post-ischaemic functional recovery when applied in a
hyperkalaemic cardioplegic solution (Galin˜anes et al., 1992),
can be rationalized by our results. Thus, it is very likely that
the protective effect of lemakalim was reduced due to
depolarization of the resting membrane potential in hyper-
kalaemic milieu. Notably, recent studies on experimental
cardioplegia are in agreement with our results: solutions
hyperpolarizing the diastolic membrane potential in rat hearts
are effective during cardioplegia (Chambers & Hearse, 1999).
Limitations
The cellular events observed during metabolic inhibition in this
study closely replicate those observed in the setting of
ischaemia/reperfusion injury; however, they might not be the
same. Therefore, our findings require further confirmation in
future whole-heart studies.
In this study, DiBac4(3) proved to be a reliable qualitative
reporter of changes in the resting membrane potential of
ventricular myocytes. However, it seems that the dye is not an
absolutely accurate measure of membrane potential at more
negative potentials, where the relationship between normalized
DiBac4(3) fluorescence intensity and actual membrane poten-
tial becomes less steep (Figure 1a). Therefore, the changes in
DiBac4(3) fluorescence can be used only for estimates in
changes in membrane potential as opposed to an exact voltage
readout. It must be noted that this does not affect the main
finding of this study, showing that the cardioprotective
mechanism of pmKATP channel activation involves resting
membrane potential hyperpolarization.
It is noted that there may be some additional effects of
P-1075 at lower concentrations on cellular processes other than
pmKATP channel activation (Jilkina et al., 2002). However, our
finding that the selective pmKATP blocker HMR 1098
completely abolished the resting membrane potential hyper-
polarizing as well as the protective effects of P-1075 strongly
supports our interpretations regarding a mechanism of action
of P-1075 being on the pmKATP in origin. Also, the findings of
this paper confirm our previous observations regarding the
important role of resting membrane potential hyperpolariza-
tion in the prevention of reoxygenation-induced Ca2þ loading
(Baczko´ et al., 2003a).
Conclusions
Results from this study show that the hyperpolarization of the
resting membrane potential caused by pmKATP activation
(Figure 2b) is sufficient to result in more effective Ca2þ
extrusion in ventricular myocytes (Figure 3b). Recent findings
from our laboratory (Baczko´ et al., 2003a) suggest that
hyperpolarization significantly reduces reverse-mode Naþ /
Ca2þ exchange activity, leading to a significant decrease
in reoxygenation-induced Ca2þ overload. Therefore, we
suggest that decreased Ca2þ loading via the Naþ /Ca2þ
exchanger may be the critical mechanism responsible for the
beneficial effects of pmKATP activation on Ca
2þ homeostasis
during reoxygenation.
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